Viewing Study NCT01713218


Ignite Creation Date: 2025-12-25 @ 4:46 AM
Ignite Modification Date: 2026-03-28 @ 1:58 PM
Study NCT ID: NCT01713218
Status: UNKNOWN
Last Update Posted: 2012-10-24
First Post: 2012-10-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer
Sponsor: Jean-Luc Van Laethem
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2012-003516-31
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View